Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
Article in Frontiers in Immunology (September 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay ValidationOptimal PD-L1 Expression Algorithm for Durvalumab in HNSCC
Article in Cancer Research Communications (January 2022)
Perspektiven der medikamentösen Tumortherapie
Book chapter (January 2022)